Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies
- 22 October 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 95 (1), 7-12
- https://doi.org/10.1007/s10549-005-9016-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation studyLaboratory Investigation, 2004
- A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasmNature, 2002
- Modeling Survival Data: Extending the Cox ModelPublished by Springer Science and Business Media LLC ,2000
- Loss of heterozygosity at D14S62 and metastatic potential of breast cancer.JNCI Journal of the National Cancer Institute, 1999
- Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast CancerJournal of Clinical Oncology, 1999
- Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomasBritish Journal of Cancer, 1999
- S-phase fraction and breast cancer - a decade of experienceBreast Cancer Research and Treatment, 1998
- Overexpression of theMTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasisInternational Journal of Cancer, 1997
- Immunohistochemistry on Histological Sections from Small (50 mg) Samples of Pulverized Breast CancerJournal of Histotechnology, 1993
- Preparation of Paraffin Blocks and Sections Containing Multiple Tissue Samples Using a Skin Biopsy PunchJournal of Histotechnology, 1990